Kodiak Sciences Inc.
KOD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001468748
No open-market purchases or sales by Kodiak Sciences Inc. insiders were filed in the last 90 days; 200 institutions reported holding it in 13F filings for Q2 2026, worth $2.36B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Kodiak Sciences Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 200
- +15 vs. Q1 2026
- Shares held
- 60.5M
- +3.84M (+6.8%) vs. Q1 2026
- Total value
- $2.36B
- +$197.8M (+9.2%) vs. Q1 2026
- New holders
- 38
- 82 more added
- Sold out
- 23
- 55 more reduced
3 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KOD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 200 | $2.36B |
| Q1 2026 | 188 | $2.21B |
| Q4 2025 | 158 | $1.61B |
| Q3 2025 | 121 | $727.8M |
| Q2 2025 | 101 | $155.7M |
| Q1 2025 | 107 | $120.3M |
| Q4 2024 | 108 | $418.7M |
| Q3 2024 | 98 | $103.0M |
| Q2 2024 | 106 | $94.3M |
| Q1 2024 | 114 | $228.0M |
| Q4 2023 | 96 | $124.7M |
| Q3 2023 | 101 | $76.5M |
| Q2 2023 | 128 | $293.6M |
| Q1 2023 | 127 | $254.8M |
| Q4 2022 | 136 | $298.2M |
| Q3 2022 | 143 | $324.6M |
| Q2 2022 | 131 | $313.1M |
| Q1 2022 | 142 | $330.5M |
| Q4 2021 | 153 | $3.82B |
| Q3 2021 | 153 | $4.37B |
| Q2 2021 | 149 | $4.18B |
| Q1 2021 | 167 | $5.02B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Kodiak Sciences Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| National Philanthropic Trust | 0 | $0 | 0.00% | −66,398−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −66,269−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −65,492−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −58,953−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −34,227−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −23,572−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −22,152−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −20,593−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −9,651−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −9,301−100.0% | Sold out |
| Verdad Advisers, LP | 0 | $0 | 0.00% | −9,115−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −7,868−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −5,976−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −5,624−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −2,862−100.0% | Sold out |
| POM Investment Strategies, LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −481−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −124−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −53−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| Skopos Labs, Inc. | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |